GEN Exclusives

More »

Feature Articles

More »
Feb 1, 2009 (Vol. 29, No. 3)

Uncovering Applications for DNA Forensics

It Is Not Just Law-Enforcement Agencies Who Are Finding a Panoply of Uses for New Tools

  • Automation Rules

    Everyone agrees that automation has a big role to play in DNA forensics, and there needs to be more of it downstream as sample-processing throughput increases. Life Technologies’ GeneMapper® ID-X software offers an automated approach for the deconvolution of DNA mixtures, according to Dr. Klevan.

    “There are many challenges for sample analysis in the field, but the one we specifically talked about in this presentation was what happens in instances in which there is more that one contributor to the sample,” he said. “The GeneMapper ID-X software streamlines the interpretation of profiles from mixed DNA samples by automating functions that would otherwise be performed manually.”

    Dr. Klevan reported that, while standardization of practices in the field is starting to evolve, there still exists significant variation in the procedures for evaluating DNA mixtures between laboratories. Consequently, two different labs can interpret the results of the data slightly differently. “GeneMapper ID-X allows you to segregate the samples based on the minimum number of contributors. It deconvolutes two-person mixtures into contributor genotypes, and provides statistical frequencies.”

    The approach to deconvoluting two-person mixtures into individual profiles uses two key inferences. First, at any locus, two alleles originating from the same person have roughly the same height; and, second, established mixture proportions remain consistent across all loci within a set profile. “The approach results in a set of genotype combinations that are scored across the profile and heterozygote peak-height ratio,” Dr. Klevan added.

  • Multiple-Capillary Systems

    As breakthroughs in reagent chemistries increase the ability to detect trace amounts of DNA, Promega is pushing the limits of available instrumentation. Recently, some of Promega’s PowerPlex 16 and PowerPlex ES System users started to notice a split, or n-1 peak, at the wVA locus, which was affecting the ability of some labs to interpret their data. This only occurred on the 4 and 16 capillary electrophoresis platform, not on single capillary systems and was more prevalent in customer labs during the winter when lab temperatures could dip. 

    The issue was traced to an insufficiently denaturing environment in the exposed portion of the capillary outside of the heating oven on the multicapillary instruments. This allowed reannealing of the unlabeled unincorporated vWA primer to the 3´ end of the tetramethylrhodomine (TMR)-labeled strand of the vWA amplicon, following electrokinetic injection. The partially double-stranded DNA migrated faster than the single-stranded amplicon and this mobility shift manifested itself as the split or n-1 peak.

    “We were in a situation where the split peak artifact was being caused by an instrumentation-related issue, but not being able to resign the instrumentation we had to come up with a work around with the chemistry” said Bob McLaren, Ph.D., senior R & D scientist. Dr. McLaren and his team found that, stretching out the pre-run time would keep this reannealing from occurring, presumably by increasing the temperature in the exposed portion of the capillary array.

    “The split would go away, but increasing the pre-run time wasn’t really enough to solve the problem,” Dr. McLaren noted. “What we eventually ended up doing was incorporating into the Internal Lane Standard 600 (ILS600) a sacrificial hybridization sequence oligonucleotide that is complementary to the vWA primer. This preferentially hybridizes to the vWA primer and thus prevents the primer from hybridizing to the 3´ end of the TMR-labeled strand of the vWA amplicon.”

    Users also noted an n-10/n-18 artifact at the vWA locus in the same STR multiplexes. Again, the root cause turned out to be an inability for already denatured DNA to be maintained in a denatured state on the exposed portion of the capillary array. In this case, the n-10/n-18 artifact was actually double-stranded vWA amplicon. In a similar fashion to the split peak solution, two complementary oligo targets (COT1 and COT2) were added into the ILS600,  which preferentially annealed to the unlabeled strand of the vWA strand, thereby preventing it from annealing to the TMR-labeled strand of the vWA amplicon.

    “The presence of these three oligonucleotides effectively eliminates both the split peak and the n-10/n-18 artifacts in both products without affecting sizing of alleles at the vWA locus—or any other locus,” Dr. McLaren explained. “The users found the problem, which turned out to be instrument related, and we went the extra mile to find a solution.”


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?